Cytotoxic activity of a tumor protease-activated pore-forming toxin

Bioconjugate Chemistry

Volumn 16, Issue 2, 2005, Pages 369-376

  Potrich, C ^a   Tomazzolli, R ^a   Dalla Serra, M ^a   Anderluh, G ^b   Malovrh, P ^b   Macek P ^b   Menestrina, G ^a   Tejuca, M ^a,c  

^a CNR   (Italy)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c UNIVERSITY OF HAVANA   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELLS; CHEMICAL ACTIVATION; CYTOTOXICITY;

AMPHIPHILICS; CATHEPSIN B; CLEAVAGE SITES; CYTOTOXIC ACTIVITIES; CYTOTOXIC EFFECTS; HUMAN RED BLOOD CELL; MATRIX METALLOPROTEASE; N-TERMINALS; PORE FORMING TOXINS; SEA ANEMONES;

TUMORS;

EQUINATOXIN; EQUINATOXIN II; PROTEINASE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BREAST CARCINOMA; CHANNEL GATING; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG BINDING; DRUG CONJUGATION; DRUG MECHANISM; ENZYME ACTIVITY; ERYTHROCYTE; FIBROSARCOMA; HUMAN; HUMAN CELL;

ACTINIA EQUINA; ACTINIARIA; ANEMONE;

EID: 15244349611     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc049873z     Document Type: Article

References (33)

1. Kreitman, R. J. and Pastan, I. (1998) Immunotoxins for targeted cancer therapy. Adv. Drug Delivery Rev. 31, 53-88.
2. Forero, A. and Lobuglio, A. F. (2003) History of antibody therapy for non-Hodgkin's lymphoma. Semin. Oncol. 30, 1-5.
3. Pastan, I. (2003) Immunotoxin containing Pseudomonas exotoxin A: a short history. Cancer Immunol. Immunother. 52, 338-341.
4. Frankel, A. E., Powell, B. L., and Lilly, M. B. (2002) Diphtheria toxin conjugate therapy of cancer. Cancer Chemother Biol Response Modif. 20, 301-313.
5. Baluna, R., Coleman, E., Jones, C., Ghetie, V., and Vitetta, E. S. (2000) The effect of a monoclonal antibody coupled to ricin A chain-derived peptides on endothelial cells in vitro: Insights into toxin-mediated vascular damage. Exp. Cell Res. 258, 417-424.
6. Thrush, G. R., Lark, L. R., Clinchy, B. C., and Vitetta, E. S. (1996) Immunotoxins: an update. Annu. Rev. Immunol. 14, 49-71.
7. Tritton, T. R. and Hickman, J. A. (1990) How to kill cancer cells: membranes and calcium signaling as targets in cancer chemotherapy. Cancer Cells 2, 95-105.
8. Harvey, A. L. (1990) Cytolytic toxins. In Handbook of toxinology (Shier, W. T., Ed.), pp 1-66. Marcel Dekker, New York.
9. Anderluh, G.; G. Menestrina (2001) Pore-forming proteins from sea anemones and the construction of immunotoxins for selective killing of harmful cells. In Bio-organic compounds: chemistry and biomedical applications (Fingerman, M., Ed.), pp 131-148, Science Publishers, Inc., Enfield, NH.
10. Pederzolli, C., Belmonte, G., Dalla Serra, M., Maček, P., and Menestrina, G. (1995) Biochemical and cytotoxic properties of conjugates of transferrin with equinatoxin II, a cytolysin from a sea anemone. Bioconjugate Chem. 6, 166-173.
11. Tejuca, M., Anderluh, G., Maček, P., Alvarez, C., Lanio, M. E., Marcet, R., Torres, D., Sarracent, J., Dalla Serra, M., and Menestrina, G. (1999) Antiparasite activity of sea anemone cytolysins on Giardia duodenalis and specific targeting with anti-Giardia antibodies. Int. J. Parasitol. 29, 489-498.
12. Potrich, C., Viero, G., Tejuca, M., Anderluh, G., Maček, P., and Menestrina, G. (2000) Construction of new immunotoxins by linking equinatoxin II to monoclonal antibodies via the biotin-avidin interaction. Cytotoxic effects on human tumor cells. Acta Biol. Sloven. 43, 47-51.
13. Avila, A. D., de Acosta, M. C., and Lage, A. (1988) A new immunotoxin built by linking a hemolytic toxin to a monoclonal antibody specific for immature T lymphocytes. Int. J. Cancer 42, 568-571.
14. Gasanov, S. E., Rael, E. D., Gasanov, N. E., and Vernon, L. P. (1995) In vitro evaluation of Pyrularia thionin-anti-CD5 immunotoxin. Cancer Immunol. Immunother. 41, 122-128.
15. Al Yahyaee, S. A. S. and Ellar, D. J. (1996) Cell targeting of a pore-forming toxin, CytA delta-endotoxin from Bacillus thuringiensis subspecies israelensis, by conjugating CytA with anti-thy 1 monoclonal antibodies and insulin. Bioconjugate Chem. 7, 451-460.
16. Panchal, R. G., Cusak, E., Cheley, S., and Bayley, H. (1996) Tumor protease-activated, pore-forming toxins from a combinatorial library. Nat. Biotechnol. 14, 852-856.
17. Liu, S. H., Bugge, T. H., and Leppla, S. H. (2001) Targeting of tumor cells by cell surface urokinase plasminogen activator-dependent anthrax toxin. J. Biol. Chem. 276, 17976-17984.
18. Rozhin, J., Sameni, M., Ziegler, G., and Sloane, B. F. (1994) Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res. 54, 6517-6525.
19. Mai, J., Waisman, D. M., and Sloane, B. F. (2000) Cell surface complex of cathepsin B/annexin II tetramer in malignant progression. Biochim. Biophys. Acta 1477, 215-230.
20. Koblinski, J. E., Ahram, M., and Sloane, B. F. (2000) Unraveling the role of proteases in cancer. Clin. Chim. Acta 291, 113-135.
21. Barrett, A. J., Rawlings, N. D., and Woessner, F. J. (2003) Handbook of Proteolyic Enzymes, two-Volume Set with CD ROM, 1-2, Academic Press, Cambridge.
22. Anderluh, G., Barlič, A., Podlesek, Z., Maček, P., Pungerčar, J., Gubensek, F., Zecchini, M., Dalla Serra, M., and Menestrina, G. (1999) Cysteine scanning mutagenesis of an eucaryotic pore-forming toxin from sea anemone: topology in lipid membranes. Eur. J. Biochem 263, 128-136.
23. Takahashi, T., Dehdarani, A. H., Yonezawa, S., and Tang, J. (1986) Porcine spleen cathepsin B is an exopeptidase. J. Biol. Chem. 261, 9375-9381.
24. Chapman, H. A., Riese, R. J., and Shi, G. P. (1997) Emerging roles for cysteine proteases in human biology. Annu. Rev. Physiol. 59, 63-88.
25. Nagase, H. and Fields, G. B. (1996) Human matrix metalloproteinase specificity studies using collagen sequence-based synthetic peptides. Biopolymers 40, 399-416.
26. Turk, B. E., Huang, L. L., Piro, E. T., and Cantley, L. C. (2001) Determination of protease cleavage site motifs using mixture-based oriented peptide libraries. Nat. Biotechnol. 19, 661-667.
27. Meyer, B. F., Stoner, M. L., Raphael, C. L., Davis, R. E., and Herrmann, R. P. (1991) Streptavidin-biotin immunotoxins: a new approach to purging bone marrow. Exp. Hematol. 19, 710-713.
28. Keller, J., Heisler, I., Tauber, R., and Fuchs, H. (2001) Development of a novel molecular adapter for the optimization of immunotoxins. J. Controlled Release 74, 259-261.
29. Kleinschmidt, M., Rudolph, R., and Lilie, H. (2003) Design of a modular immunotoxins connected by polyionic adapter peptides. J. Mol. Biol. 327, 445-452.
30. Athanasiadis, A., Anderluh, G., Maček, P., and Turk, D. (2001) Crystal structure of the soluble form of equinatoxin II, a pore-forming toxin from the sea anemone Actinia equina. Structure 9, 341-346.
31. Malovrh, P., Viero, G., Dalla Serra, M., Podlesek, Z., Lakey, J. H., Maček, P., Menestrina, G., and Anderluh, G. (2003) A novel mechanism of pore-formation: equinatoxin penetration of membrane by a N-terminal amphipatic region. J. Biol. Chem. 278, 22678-22685.
32. Anderluh, G., Dalla Serra, M., Viero, G., Guella, G., Maček, P., and Menestrina, G. (2003) Pore formation by equinatoxin II, an eukaryotic protein toxin, occurs by induction of non-lamellar lipid structures. J. Biol. Chem. 278, 45216-45223.
33. Hong, Q., Gutierrez-Aguirre, I., Barlič, A., Malovrh, P., Kristan, K., Podlesek, Z., Maček, P., Turk, D., Gonzalez-Manas, J. M., Lakey, J. H., and Anderluh, G. (2002) Two-step membrane binding by Equinatoxin II, a pore-forming toxin from the sea anemone, involves an exposed aromatic cluster and a flexible helix. J. Biol. Chem. 277, 41916-41924.